This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Prescribing Information and Adverse Event reporting statement can be found at the bottom of this page.

GSK has partnered with experts across healthcare to offer webinars and events on the subjects that matter to you. If you missed the live event, you will find our on-demand webinars in the ‘past’ tab below.

Filter By
Reset all
Therapy
  • Severe asthma

  • Asthma

  • COPD

  • Oncology

  • Vaccines

  • Immunology

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

RSV: The risk for adults aged 60 and over
Speakers:Professor Harish Nair, Group Lead, Respiratory Viral Epidemiology Programme, University of Edinburgh
This is a promotional webinar organised and funded by GSK for UK Healthcare Professionals or other relevant decision makers only. GSK products will be discussed. Please do not forward on. Expert led virtual webinar on RSV, including the impact on adults 60 years and over and how to help protect eligible patients.
18 Apr, 2024 o 13:00 GMT+01:00
PM-GB-RSA-WCNT-240002 March 2024
Filter By
Reset all
Therapy
  • Severe asthma

  • Asthma

  • COPD

  • Oncology

  • Vaccines

  • Immunology

Duration
  • 30 minutes

  • 1 hour

  • 1.5 hours

  • 2 hours

RSV: The risk for adults aged 60 and over
Speakers:Professor Harish Nair, Group Lead, Respiratory Viral Epidemiology Programme, University of Edinburgh
This is a promotional webinar organised and funded by GSK for UK Healthcare Professionals or other relevant decision makers only. GSK products will be discussed. Please do not forward on. Expert led virtual webinar on RSV, including the impact on adults 60 years and over and how to help protect eligible patients.
18 Apr, 2024 o 13:00 GMT+01:00
PM-GB-RSA-WCNT-240002 March 2024

Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellowcard in the Google Play or Apple App store. Adverse events should also be reported to GlaxoSmithKline on +44 (0)800 221 441 and UKSafety@gsk.com